Compare Sibanye Stillwater Ltd (SBSW) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sibanye Stillwater Ltd vs Twist Bioscience Corp — how do they compare? Sibanye Stillwater Ltd trades at $8.59 (market cap $5.66B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Sibanye Stillwater Ltd and Twist Bioscience Corp are close in size by market cap, and Sibanye Stillwater Ltd pays a 3.89% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| SBSW | TWST | |
|---|---|---|
Market Cap | $5.66B | $5.45B |
Sector | Basic Materials | Health |
52-Week High | $21.12 | $102.88 |
52-Week Low | $7.27 | $24.16 |
Enterprise Value | $7.28B | $5.37B |
Dividend Yield | 3.89% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sibanye Stillwater Ltd
Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
